Article thumbnail

Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: A randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study)

By Gernot Schilcher, Werner Ribitsch, Ronald Otto, Rupert H Portugaller, Franz Quehenberger, Martini Truschnig-Wilders, Robert Zweiker, Philipp Stiegler, Marianne Brodmann, Klemens Weinhandl and Joerg H Horina
Topics: Study Protocol
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2007). A: Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation
  2. (2001). AK: Requests for body computed tomography: increasing workload, increasing indications and increasing age. Eur Radiol
  3. (2003). AL: The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.
  4. (2000). Chertow GM: Predicting acute renal failure after coronary bypass surgery: cross-validation of two risk-stratification algorithms. Kidney Int
  5. (2005). Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet
  6. (2007). Devarajan P: NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol
  7. (2008). Devarajan P: Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study.
  8. (1994). Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents.
  9. (2005). EP: A clinical score to predict acute renal failure after cardiac surgery.
  10. (2004). Erley CM: What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol
  11. (2006). Follow-up of patients with contrast-induced nephropathy. Kidney Int Suppl
  12. (2001). Frey FJ: Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.
  13. (2006). Gadolinium–a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant
  14. (2008). Garovic VD: Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. Nephrol Dial Transplant
  15. (2009). Garovic VD: Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings?
  16. (2006). HS: Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. JA m Coll Cardiol
  17. (2002). Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation
  18. (2007). JM: The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. JA m Coll Cardiol
  19. (2006). Lameire N: Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation
  20. (2006). Nacetylcysteine and contrast-induced nephropathy in primary angioplasty.
  21. (2007). Nakao K: Neutrophil gelatinase-associated lipocalin as the realtime indicator of active kidney damage. Kidney Int
  22. (2009). Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
  23. (2009). Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation. Kidney Blood Press Res
  24. (2008). Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res
  25. (2009). NGAL Meta-analysis Investigator Group: Accuracy of neutrophil gelatinaseassociated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis.
  26. (2009). Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery–a prospective cohort study. Crit Care Med
  27. (2008). Palevsky PM: Prevention of contrast-induced nephropathy with volume expansion.
  28. (2005). Patzak A: Renal haemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration. Nephrol Dial Transplant
  29. (2002). Roskamm H: Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med
  30. (2008). Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med
  31. (2010). Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases. Pediatr Int
  32. (2009). Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney Blood Press Res
  33. (2004). Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J
  34. (2009). Testing new biomarkers for acute kidney injury: association, prediction, and intervention.
  35. (2004). TP: Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA
  36. (2010). Wong PY: Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem
  37. (1997). WW: Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.
  38. (2000). Zidek W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.